Montefiore Einstein Comprehensive Cancer Center | Strategic Alliance Partners

Latest from Montefiore Einstein Comprehensive Cancer Center


Keeping Up With COVID-19: Adaptability Is the Strongest Weapon in the Arsenal

April 17, 2020

Balazs Halmos, MD, MS, provides insight on preventive measures put in place at his institution, day-to-day challenges faced in practice, and how he is staying connected with the broader community to share information.

Biomarkers Inform Immunotherapy Decisions in Advanced NSCLC

March 20, 2020

Balazs Halmos, MD, MA, discusses the advances that have been made in the treatment of patients with metastatic non–small cell lung cancer, ongoing biomarker research, and the importance of molecular testing.

ctDNA Advances Perpetuate Progress Achieved With Osimertinib in EGFR+ NSCLC

March 17, 2020

Balazs Halmos, MD, discusses the implications of the emergence of osimertinib in the frontline treatment of patients with EGFR-mutated non–small cell lung cancer, the efforts being made to address resistance to the third-generation EGFR TKI, and the promise of circulating tumor DNA in the space.

Dr. Sparano on the Utility of Liquid Biopsies in Breast Cancer

January 21, 2020

Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, professor of Medicine & Obstetrics, Gynecology, and Women’s Health at the Albert Einstein College of Medicine, and associate chairman for Clinical Research in the Department of Oncology at Montefiore Medical Center, discusses the utility of liquid biopsies in breast cancer.

Dr. Rajdev on the Difference Between Cancers and Carcinomas in NETs

November 06, 2019

Lakshmi N. Rajdev, MD, an associate professor, Department of Medicine (Oncology), at Albert Einstein College of Medicine, Montefiore Medical Center, discusses the difference between cancers and carcinomas in neuroendocrine tumors (NETs).

Montefiore Study May Help Establish Patient Criteria for Proton Therapy

May 21, 2019

In an effort to build more sophisticated protocols that keep QoL and cost questions at the forefront, Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine’s Institute for Onco-Physics created a mathematical model to identify the optimal candidates for proton therapy, the most modern form of radiation therapy for patients with head and neck cancers.

Dr. Gartrell on Tolerability of SM-88 in Prostate Cancer

April 01, 2019

Benjamin A. Gartrell, MD, assistant professor of urology, Albert Einstein College of Medicine, medical oncologist, Montefiore Medical Center, discusses the tolerability of SM-88 in the treatment of patients with prostate cancer.

Dr. Sparano on Improving Liquid Biopsies in Breast Cancer

January 30, 2019

Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, Montefiore Medical Center, discusses ways to improve the clinical utility of liquid biopsies in the treatment of patients with breast cancer.

Dr. Perez-Soler on Immunotherapy Advances in SCLC

January 07, 2019

Roman Perez-Soler, MD, chairman of the Department of Oncology and chief of the Division of Medical Oncology at Montefiore Medical Center, discusses recent advances in immunotherapy for the treatment of patients with small cell lung cancer.

Dr. Halmos on Second-Line Treatment in Metastatic Squamous NSCLC

November 02, 2018

Balazs Halmos, MD, MS, director of thoracic oncology and director of clinical cancer genomics, Montefiore Medical Center, discusses second-line treatment for patients with metastatic squamous non–small cell lung cancer (NSCLC).

x